Serious mental illness may increase risk of heart disease in young adults

"Previous research has indicated that people diagnosed with a serious mental illness die 10-20 years earlier than the general population, and their leading cause of death is heart disease," said study lead author Rebecca C. Rossom, M.D., M.S., a senior research investigator in behavioral health at the Center for Chronic Care Innovation at HealthPartners Institute in Minneapolis, Minnesota. "Our study focused on the contribution of cardiovascular risk factors, such as blood pressure, cholesterol, blood sugar, body mass index and smoking status, to compare overall heart disease risk for people with and without serious mental illness."

The researchers believe this is the first study to examine estimated 30-year (lifetime) cardiovascular risk in a large sample of adult outpatients diagnosed with bipolar disorder, schizophrenia or schizoaffective disorder - three serious mental illnesses specific to this study. Many previous studies of cardiovascular risk for people with serious mental illness have included only people who were hospitalized, and they tend to have more severe mental illness and frailer health than outpatients, according to Rossom. In contrast, this study, included a large sample of non-hospitalized U.S. adults.

According to the National Institute of Mental Health, bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental illness that causes unusual shifts in mood, energy, activity levels, concentration and the ability to carry out day-to-day tasks. Schizophrenia can cause hallucinations, delusions or disorganized speech. People with schizophrenia may seem like they have lost touch with reality, which can cause significant distress for the individual, their family and friends. The symptoms of schizophrenia can be persistent and disabling. Schizoaffective disorder is defined by the Diagnostic and Statistical Manual of Mental Disorders as an uninterrupted duration of illness during which there is a major mood episode (manic or depressive) in addition to meeting criteria for schizophrenia.

This analysis evaluated health data for nearly 600,000 people, ages 18-75 years, who visited a primary care clinic in Minnesota and Wisconsin between January 2016 and September 2018. Nearly 2%, or approximately 11,000 adults, had a diagnosis of serious mental illness. Of these, 70% were diagnosed with bipolar disorder, 18% with schizoaffective disorder and 12% with schizophrenia. On average, people with serious mental illness were more likely to be younger; female; self-identify as Black race, Native American, Alaskan race or of multiple races; and be insured by Medicaid or Medicare, compared to their counterparts not diagnosed with one of those three serious mental illnesses.

Prediction models providing a standardized metric were used to assess cardiovascular risk factors and predict the likelihood of a heart attack, stroke or cardiovascular death. To assess 10-year risk, the American College of Cardiology/American Heart Association's atherosclerotic cardiovascular risk scoring tool was used for adults ages 40-75 years old. The Framingham Risk Score was used to estimate 30-year cardiovascular risk among adults ages 18-59 years old.

"Even at younger ages, people with serious mental illness had a higher risk of heart disease than their peers, which highlights the importance of addressing cardiovascular risk factors for these individuals as early as possible," Rossom said. "Interventions to address heart disease risk for these individuals are maximally beneficial when initiated at younger ages.

"We encourage health care systems and clinicians to use the 30-year cardiovascular risk estimates for young adults with serious mental illness, as these may be used starting at age 18," she said. "Right now, estimates of 10-year heart disease risk are used most frequently, and they cannot be applied until people are at least 40 years old, which is too late to start addressing heart disease risk in people with serious mental illness."

Co-authors include Stephanie A. Hooker, Ph.D., M.P.H.; Patrick J. O'Connor, M.D., M.A., M.P.H.; A. Lauren Crain, Ph.D.; and JoAnn M. Sperl-Hillen, M.D. Authors' disclosures are listed in the abstract.

This work was funded by a Cooperative Agreement with the National Institute of Mental Health (NIMH), a division of the National Institutes of Health.

Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association's overall financial information are available here.